Armbrecht H J, Hodam T L, Boltz M A
Geriatric Research, Education, and Clinical Center (11G-JB), St. Louis VA Medical Center, St. Louis, MO 63125, USA.
Arch Biochem Biophys. 2003 Jan 15;409(2):298-304. doi: 10.1016/s0003-9861(02)00636-7.
In the kidney, 25-hydroxyvitamin D(3) (25(OH)D) is converted to 1,25-dihydroxyvitamin D(3) (1,25(OH)(2)D) by the 25(OH)D(3)-1alpha-hydroxylase enzyme, which contains a terminal cytochrome P450 (CYP1alpha) (systematic name: CYP27B1). Likewise, the kidney also produces 24,25-dihydroxyvitamin D(3) and 1,24,25-trihydroxyvitamin D(3) via a 24-hydroxylase whose terminal cytochrome P450 is CYP24. The purpose of this study was to characterize the transcriptional regulation of the CYP1alpha and CYP24 genes by parathyroid hormone (PTH) and 1,25(OH)(2)D in the kidney. Promoter-reporter gene constructs were transfected into opossum kidney (OK) cells, a renal proximal tubular cell line with endogenous PTH and 1,25(OH)(2)D receptors. PTH and forskolin stimulated CYP1alpha promoter activity via a cAMP-dependent pathway acting through the phosphorylation of CREB (cAMP-dependent response element-binding protein). This stimulation did not require new protein synthesis but may be modulated by short-lived proteins. 1,25(OH)(2)D modestly inhibited basal and forskolin-stimulated CYP1alpha promoter activity. The stimulation of CYP1alpha promoter activity by PTH and forskolin can account for the effect of these hormones on renal CYP1alpha mRNA levels. CYP24 promoter activity in transfected cells was increased by both 1,25(OH)(2)D and PTH, but there was no interaction between the two. The modest effects of 1,25(OH)(2)D and PTH on promoter activity and their lack of interaction do not account for the effects of these hormones on renal CYP24 mRNA levels. This suggests that there may be important posttranscriptional regulation of CYP24 mRNA in the kidney.
在肾脏中,25-羟维生素D(3)(25(OH)D)通过25(OH)D(3)-1α-羟化酶转化为1,25-二羟维生素D(3)(1,25(OH)(2)D),该酶含有末端细胞色素P450(CYP1α)(系统名称:CYP27B1)。同样,肾脏还通过一种末端细胞色素P450为CYP24的24-羟化酶产生24,25-二羟维生素D(3)和1,24,25-三羟维生素D(3)。本研究的目的是表征甲状旁腺激素(PTH)和1,25(OH)(2)D对肾脏中CYP1α和CYP24基因的转录调控。将启动子-报告基因构建体转染入负鼠肾(OK)细胞,这是一种具有内源性PTH和1,25(OH)(2)D受体的肾近端小管细胞系。PTH和福斯可林通过作用于CREB(cAMP依赖性反应元件结合蛋白)磷酸化的cAMP依赖性途径刺激CYP1α启动子活性。这种刺激不需要新的蛋白质合成,但可能受到短寿命蛋白质的调节。1,25(OH)(2)D适度抑制基础和福斯可林刺激的CYP1α启动子活性。PTH和福斯可林对CYP1α启动子活性的刺激可以解释这些激素对肾CYP1α mRNA水平的影响。转染细胞中的CYP24启动子活性在1,25(OH)(2)D和PTH作用下均增加,但二者之间没有相互作用。1,25(OH)(2)D和PTH对启动子活性的适度影响及其缺乏相互作用并不能解释这些激素对肾CYP24 mRNA水平的影响。这表明肾脏中CYP24 mRNA可能存在重要的转录后调控。